Our results identified a direct and functional connection between IL-33 and 5-FU sensitivity in CRC, highlighted the involvement of antitumoral T cell responses in this process through a signaling cascade activated by annexin A1, and unveiled the detailed molecular mechanisms underlying the enhanced 5-FU sensitivity of CRC cells. The gene discussed is ANXA1; the disease is colorectal carcinoma.